Orna Therapeutics

Orna Therapeutics develops innovative methods and drugs in the field of RNA therapeutics. The firm plans to use its products to help treat various kinds of diseases.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
  • Combo news

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
$  Share Price
Series B16 Aug 2022
Series A24 Feb 2021
Seed1 Jan 2020

*** - To view the data, please log into your account or create a new one.


MPM CapitalMPM Capital

News related to Orna Therapeutics

Orna TherapeuticsOrna Therapeutics • 5 Jan 2023

Simnova and Orna Therapeutics Collaborate to Advance Orna's ...

Simnova and Orna Therapeutics Collaborate to Advance Orna's Next Generation Circular RNA Technology in China ...

Orna TherapeuticsOrna Therapeutics • 16 Aug 2022

BioImpact Capital Announces a Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer

BioImpact Capital, an affiliate of MPM Capital ("MPM"), announced today that Orna Therapeutics ...


Orna Therapeutics Twitter